DexCom, Inc. vs Toronto-Dominion Bank — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: Toronto-Dominion Bank is far larger — about 5.9× DexCom, Inc.'s market cap, and Toronto-Dominion Bank pays a 2.63% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | TD | |
|---|---|---|
Market Cap | $33.79B | $200.48B |
Sector | Health | Financials |
52-Week High | $89.53 | $124.80 |
52-Week Low | $54.84 | $72.85 |
Enterprise Value | $33.24B | — |
Dividend Yield | — | 2.63% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →